高分辨率3D显微镜分析死后阿尔茨海默病大脑内体形态的进展
Shannon E Rose1,2, C Andrew Williams1,2, Dale W Hailey2
1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA,United States.
Frontiers in neuroscience
|January 31, 2024
概括
这项研究介绍了一种新的高分辨率3D成像协议,用于量化阿尔茨海默病 (AD) 脑组织中的神经元内分体. 这种方法有助于理解在零星晚期发病的AD (LOAD) 中的内溶酶体网络 (ELN) 功能障碍.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 异常的内溶酶体形态是阿尔茨海默病 (AD) 的早期指标.
- 全基因组关联研究 (GWAS) 将内溶酶体网络 (ELN) 基因与零星,晚发性AD (LOAD) 的风险增加联系起来.
- 在死后脑组织中研究ELN囊泡,由于囊泡大小小和高分辨率成像要求,存在重大方法挑战.
研究的目的:
- 为在死后的AD脑组织中提供神经元内体的高分辨率3D形态量化提供详细的协议.
- 建立强大的方法来分析零星 LOAD 中的 ELN 病理.
- 为了促进在大型AD队伍中ELN功能障碍的未来研究.
主要方法:
- 死后脑组织的免疫光染色.
- 同焦点成像与图像解卷成像.
- Imaris软件分析管道用于3D形态定量化.
主要成果:
- 展示了一种用于高分辨率3D内分体定量化的新方案.
- 来自LOAD捐赠者的神经元内基因组形态数据的演示.
- 在不同的AD神经病理学中验证技术.
结论:
- 开发的协议使得AD中神经元内体的详细形态分析成为可能.
- 这种方法提升了对零星 LOAD 中的 ELN 功能障碍和细胞病理学的理解.
- 这些技术被优化用于大型研究队伍的应用,以加速AD研究.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.伊玛丽斯·伊玛丽斯 (Imaris) 是一个同焦点显微镜的共焦显微镜.早期的内分泌体内分泌体.细胞内溶酶体网络的内溶酶体网络高分辨率成像成像技术神经元神经元的神经元死亡后的脑部研究更多相关视频
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.0K
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
487
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
